Sunshine Biopharma Inc. - 8-K Filing

Sunshine Biopharma reduced the exercise price of its Series B Warrants to $1.2046 due to recent common stock sales under an at-the-market offering. (Items: 8.01 Other Events)

SEC EDGAR ·

Tickers: $SBFM

Read the full article at SEC EDGAR

More Regulatory news